A novel mir-451a isomir, associated with amelanotypic phenotype, acts as a tumor suppressor in melanoma by retarding cell migration and invasion

PLoS ONE

Volumn 9, Issue 9, 2014, Pages e120-

  Babapoor, Sankhiros ^a   Fleming, Elizabeth ^a   Wu, Rong ^a   Dadras, Soheil S ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 144; MICRORNA 30B; MICRORNA 451A; MICRORNA 590; MICRORNA LET 7A; MICRORNA LET 7F; MICRORNA LET 7I; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AMELANOTIC MELANOMA; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; KERATINOCYTE; MAJOR CLINICAL STUDY; MELANOMA CELL LINE; MIGRATION INHIBITION; NEVUS CELL; PHENOTYPE; PHENOTYPIC VARIATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; SEQUENCE ANALYSIS; CELL MOTION; GENETICS; MELANOMA; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; MELANOMA; MICRORNAS; NEOPLASM INVASIVENESS; PHENOTYPE;

EID: 84907210648     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107502     Document Type: Article

References (43)

1. Howlader N NA, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al. (eds). (2013) SEER Stat Fact Sheets: Skin (excl. Basal and Squamous). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute posted to the SEER web site, 2012 ed. Bethesda, MD: http://seer. cancer.gov/csr/19752009pops09/resultssingle/sect01table.01.pdf.
2. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949-954.
3. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, et al. (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353: 2135-2147.
4. Dadras SS (2011) Molecular diagnostics in melanoma: current status and perspectives. Archives of pathology & laboratory medicine 135: 860-869.
5. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Godshalk SE, Paranjape T, Nallur S, Speed W, Chan E, et al. (2011) A Variant in a MicroRNA complementary site in the 3′ UTR of the KIT oncogene increases risk of acral melanoma. Oncogene 30: 1542-1550.
7. Chan E, Patel R, Nallur S, Ratner E, Bacchiocchi A, et al. (2011) MicroRNA signatures differentiate melanoma subtypes. Cell Cycle 10.
8. Ma Z, Swede H, Cassarino D, Fleming E, Fire A, et al. (2011) Up-regulated Dicer expression in patients with cutaneous melanoma. PLoS One 6: e20494.
9. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, et al. (2009) Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proceedings of the National Academy of Sciences of the United States of America 106: 1814-1819.
10. Levy C, Khaled M, Iliopoulos D, Janas MM, Schubert S, et al. (2010) Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Molecular cell 40: 841-849.
11. Mazar J, DeYoung K, Khaitan D, Meister E, Almodovar A, et al. (2010) The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS One 5: e13779.
12. Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, et al. (2011) microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. The EMBO journal.
13. Segura MF, Belitskaya-Levy I, Rose AE, Zakrzewski J, Gaziel A, et al. (2010) Melanoma MicroRNA signature predicts post-recurrence survival. Clinical cancer research: an official journal of the American Association for Cancer Research 16: 1577-1586.
14. Kozubek J, Ma Z, Fleming E, Duggan T, Wu R, et al. (2013) In-Depth Characterization of microRNA Transcriptome in Melanoma. PLoS One 8: e72699.
15. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, et al. (2008) Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome research 18: 610-621.
16. Griffiths-Jones S (2004) The microRNA Registry. Nucleic Acids Res 32: D109- 111.
17. Fu H, Tie Y, Xu C, Zhang Z, Zhu J, et al. (2005) Identification of human fetal liver miRNAs by a novel method. FEBS letters 579: 3849-3854.
18. Vaz C, Ahmad HM, Bharti R, Pandey P, Kumar L, et al. (2013) Analysis of the microRNA transcriptome and expression of different isomiRs in human peripheral blood mononuclear cells. BMC research notes 6: 390.
19. Ahn HW, Morin RD, Zhao H, Harris RA, Coarfa C, et al. (2010) MicroRNA transcriptome in the newborn mouse ovaries determined by massive parallel sequencing. Molecular human reproduction 16: 463-471.
20. Marti E, Pantano L, Banez-Coronel M, Llorens F, Minones-Moyano E, et al. (2010) A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic acids research 38: 7219-7235.
21. Guo L, Zhao Y, Zhang H, Yang S, Chen F (2013) Close association between paralogous multiple isomiRs and paralogous/orthologues miRNA sequences implicates dominant sequence selection across various animal species. Gene 527: 624-629.
22. Slominski A, Tobin DJ, Shibahara S, Wortsman J (2004) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiological reviews 84: 1155-1228.
23. Hsiao JJ, Fisher DE (2014) The roles of microphthalmia-associated transcription factor and pigmentation in melanoma. Archives of biochemistry and biophysics.
24. Slominski A, Zmijewski MA, Pawelek J (2012) L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment cell & melanoma research 25: 14-27.
25. Slominski AT, Carlson JA (2014) Melanoma resistance: a bright future for academicians and a challenge for patient advocates. Mayo Clinic proceedings 89: 429-433.
26. Hemesath TJ, Price ER, Takemoto C, Badalian T, Fisher DE (1998) MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391: 298-301.
27. Johannessen CM, Johnson LA, Piccioni F, Townes A, Frederick DT, et al. (2013) A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature 504: 138-142.
28. Rasmussen KD, Simmini S, Abreu-Goodger C, Bartonicek N, Di Giacomo M, et al. (2010) The miR-144/451 locus is required for erythroid homeostasis. The Journal of experimental medicine 207: 1351-1358.
29. Masaki S, Ohtsuka R, Abe Y, Muta K, Umemura T (2007) Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochemical and biophysical research communications 364: 509-514.
30. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, et al. (2009) microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clinical cancer research: an official journal of the American Association for Cancer Research 15: 2281-2290.
31. Godlewski J, Nowicki MO, Bronisz A, Nuovo G, Palatini J, et al. (2010) MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Molecular cell 37: 620-632.
32. Wang R, Wang ZX, Yang JS, Pan X, De W, et al. (2011) MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 30: 2644-2658.
33. Tian Y, Nan Y, Han L, Zhang A, Wang G, et al. (2012) MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. International journal of oncology 40: 1105-1112.
34. Brozyna AA, Jozwicki W, Carlson JA, Slominski AT (2013) Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma. Human pathology 44: 2071-2074.
35. Dore LC, Amigo JD, Dos Santos CO, Zhang Z, Gai X, et al. (2008) A GATA-1- regulated microRNA locus essential for erythropoiesis. Proceedings of the National Academy of Sciences of the United States of America 105: 3333-3338.
36. Poell JB, van Haastert RJ, de Gunst T, Schultz IJ, Gommans WM, et al. (2012) A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability. PLoS One 7: e43569.
37. Xu Y, Brenn T, Brown ER, Doherty V, Melton DW (2012) Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. British journal of cancer 106: 553-561.
38. Bergamaschi A, Katzenellenbogen BS (2012) Tamoxifen downregulation of miR-451 increases 14-3-3zeta and promotes breast cancer cell survival and endocrine resistance. Oncogene 31: 39-47.
39. Doeden K, Ma Z, Narasimhan B, Swetter SM, Detmar M, et al. (2009) Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis. Journal of cutaneous pathology 36: 772-780.
40. Viros A, Fridlyand J, Bauer J, Lasithiotakis K, Garbe C, et al. (2008) Improving melanoma classification by integrating genetic and morphologic features. PLoS Med 5: e120.
41. Hanna JA, Wimberly H, Kumar S, Slack F, Agarwal S, et al. (2012) Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization. BioTechniques 52: 235-245.
42. Zhu N, Lalla R, Eves P, Brown TL, King A, et al. (2004) Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone. British journal of cancer 90: 1457-1463.
43. Hall DMS, Brooks SA (2001) In Vitro Invasion Assay Using Matrigel. In: Brooks SA, Schumacher U, editors. Metastasis Research Protocols, Vol 2. Totowa, New Jersey: Humana Press Inc. pp. 61-70.